Serum total antioxidant capacity and enzymatic defence of dogs with chronic heart failure and atrial fibrillation: a preliminary study

1Atkins C., Bonagura J., Ettinger S., Fox P., Gordon S., Häggström J., Hamlin R., Keene B., Luis-Fuentes V., Stepien R.: Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med 2009, 23, 1142–1150. Atkins C. Bonagura J. Ettinger S. Fox P. Gordon S. Häggström J. Hamlin R. Keene B. Luis-Fuentes V. Stepien R. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease J Vet Intern Med 2009 23 1142 115010.1111/j.1939-1676.2009.0392.xSearch in Google Scholar

2Brigelius-Flohé R., Maiorino M.: Glutathione peroxidases. Biochim Biophys Acta 2013, 1830, 3289–3303. Brigelius-Flohé R. Maiorino M. Glutathione peroxidases Biochim Biophys Acta 2013 1830 3289 330310.1016/j.bbagen.2012.11.020Search in Google Scholar

3Castro P.F., Díaz-Araya G., Nettle D., Corbalán R., Pérez O., Nazzal C., Larrain G., Lavandero S.: Effects of early decrease in oxidative stress after medical therapy in patients with class IV congestive heart failure. Am J Cardiol 2002, 89, 236–239. Castro P.F. Díaz-Araya G. Nettle D. Corbalán R. Pérez O. Nazzal C. Larrain G. Lavandero S. Effects of early decrease in oxidative stress after medical therapy in patients with class IV congestive heart failure Am J Cardiol 2002 89 236 23910.1016/S0002-9149(01)02211-1Search in Google Scholar

4Cornell C.C., Kittleson M.D., Della Torre P., Häggström J., Lombard C.W., Pedersen H.D., Vollmar A., Wey A.: Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med 2004, 18, 311–321. Cornell C.C. Kittleson M.D. Della Torre P. Häggström J. Lombard C.W. Pedersen H.D. Vollmar A. Wey A. Allometric scaling of M-mode cardiac measurements in normal adult dogs J Vet Intern Med 2004 18 311 32110.1111/j.1939-1676.2004.tb02551.xSearch in Google Scholar

5Dieterich S., Bieligk U., Beulich K., Hasenfuss G., Prestle J.: Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. Circulation 2000, 101, 33–39. Dieterich S. Bieligk U. Beulich K. Hasenfuss G. Prestle J. Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart Circulation 2000 101 33 3910.1161/01.CIR.101.1.33Search in Google Scholar

6Dong L.Y., Li S., Zhen Y.L., Wang Y.N., Shao X., Luo Z.G.: Cardioprotection of vitexin on myocardial ischemia/reperfusion injury in rat via regulating inflammatory cytokines and MAPK pathway. Am J Chin Med 2013, 41, 1251–1266. Dong L.Y. Li S. Zhen Y.L. Wang Y.N. Shao X. Luo Z.G. Cardioprotection of vitexin on myocardial ischemia/reperfusion injury in rat via regulating inflammatory cytokines and MAPK pathway Am J Chin Med 2013 41 1251 126610.1142/S0192415X13500845Search in Google Scholar

7Dukes-McEwan J., Borgarelli M., Tidholm A., Vollmar A.C., Häggström J.: ESVC taskforce for canine dilated cardiomyopathy: proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy. J Vet Cardiol 2003, 5, 7–19. Dukes-McEwan J. Borgarelli M. Tidholm A. Vollmar A.C. Häggström J. ESVC taskforce for canine dilated cardiomyopathy: proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy J Vet Cardiol 2003 5 7 1910.1016/S1760-2734(06)70047-9Search in Google Scholar

8Ettinger S.J., Suter P.F.: The recognition of cardiac disease and congestive heart failure. In: Canine Cardiology edited by S.J. Ettinger, P.F. Suter, W.B. Saunders, Philadelphia, 1970, p. 5. Ettinger S.J. Suter P.F. The recognition of cardiac disease and congestive heart failure In Canine Cardiology edited by EttingerS.J. SuterP.F. SaundersW.B. Philadelphia 1970 p 5Search in Google Scholar

9Flores-Mateo G., Carrillo-Santisteve P., Elosua R., Guallar E., Marrugat J., Bleys J., Covas M.I.: Antioxidant enzyme activity and coronary heart disease: meta-analyses of observational studies. Am J Epidemiol 2009, 170, 135–147. Flores-Mateo G. Carrillo-Santisteve P. Elosua R. Guallar E. Marrugat J. Bleys J. Covas M.I. Antioxidant enzyme activity and coronary heart disease: meta-analyses of observational studies Am J Epidemiol 2009 170 135 14710.1093/aje/kwp11219465742Search in Google Scholar

10Freeman L.M., Brown D.J., Rush J.E.: Antioxidant status in dogs with idiopathic dilated cardiomyopathy. J Nutr 1998, 128, 2768S–2770S. Freeman L.M. Brown D.J. Rush J.E. Antioxidant status in dogs with idiopathic dilated cardiomyopathy J Nutr 1998 128 2768S 2770 S10.1093/jn/128.12.2768S9868262Search in Google Scholar

11Freeman L.M., Rush J.E., Milbury P.E., Blumberg J.B.: Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure. J Vet Intern Med 2005, 19, 537–541. Freeman L.M. Rush J.E. Milbury P.E. Blumberg J.B. Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure J Vet Intern Med 2005 19 537 54110.1111/j.1939-1676.2005.tb02724.xSearch in Google Scholar

12Galeotti T., Borrello S., Masotti L.: Oxy-radical sources, scavenger systems and membrane damage in cancer cells. In: Oxygen Radicals: Systemic events and disease processes edited by D.K. Das, W.B. Essman, Karger, Basel, 1990, pp. 129–148. Galeotti T. Borrello S. Masotti L. Oxy-radical sources, scavenger systems and membrane damage in cancer cells In Oxygen Radicals: Systemic events and disease processes edited by DasD.K. EssmanW.B. Karger, Basel 1990 pp 129 14810.1159/000418006Search in Google Scholar

13Guglielmini C., Chetboul V., Pietra M., Pouchelon J.L., Capucci A., Cipone M.: Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs. Vet J 2000, 160, 235–241. Guglielmini C. Chetboul V. Pietra M. Pouchelon J.L. Capucci A. Cipone M. Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs Vet J 2000 160 235 24110.1053/tvjl.2000.050611061960Search in Google Scholar

14Hetyey C.S., Manczur F., Dudás-Györki Z., Reiczigel J., Ribiczey P., Vajdovich P., Vörös K.: Plasma antioxidant capacity in dogs with naturally occurring heart diseases. J Vet Med A Physiol Pathol Clin Med 2007, 54, 36–39. Hetyey C.S. Manczur F. Dudás-Györki Z. Reiczigel J. Ribiczey P. Vajdovich P. Vörös K. Plasma antioxidant capacity in dogs with naturally occurring heart diseases J Vet Med A Physiol Pathol Clin Med 2007 54 36 3910.1111/j.1439-0442.2007.00911.x17359453Search in Google Scholar

15Kodydková J., Vávrová L., Kocík M., Žák A.: Human catalase, its polymorphisms, regulation and changes of its activity in different diseases. Folia Biol (Praha) 2014, 60, 153–167. Kodydková J. Vávrová L. Kocík M. Žák A. Human catalase, its polymorphisms, regulation and changes of its activity in different diseases Folia Biol (Praha) 2014 60 153 167Search in Google Scholar

16Krupa W., Rozwodowska M., Sielski S., Czarnecka-Żaba E., Fabiszak T., Drewa G., Kasprzak M., Kubica J.: Influence of cardiac resynchronization therapy on oxidative stress markers in patients with chronic heart failure. Cardiol J 2014, 21, 576–582. Krupa W. Rozwodowska M. Sielski S. Czarnecka-Żaba E. Fabiszak T. Drewa G. Kasprzak M. Kubica J. Influence of cardiac resynchronization therapy on oxidative stress markers in patients with chronic heart failure Cardiol J 2014 21 576 58210.5603/CJ.a2014.005125471244Search in Google Scholar

17Marklund S.L.: Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA 1982, 79, 7634–7638. Marklund S.L. Human copper-containing superoxide dismutase of high molecular weight Proc Natl Acad Sci USA 1982 79 7634 763810.1073/pnas.79.24.76343474026961438Search in Google Scholar

18Mattera R., Benvenuto M., Giganti M.G., Tresoldi I., Pluchinotta F.R., Bergante S., Tettamanti G., Masuelli L., Manzari V., Modesti A., Bei R.: Effects of polyphenols on oxidative stress-mediated injury in cardiomyocytes. Nutrients 2017, 20, 523. Mattera R. Benvenuto M. Giganti M.G. Tresoldi I. Pluchinotta F.R. Bergante S. Tettamanti G. Masuelli L. Manzari V. Modesti A. Bei R. Effects of polyphenols on oxidative stress-mediated injury in cardiomyocytes Nutrients 2017 20 52310.3390/nu9050523545225328531112Search in Google Scholar

19Menaut P., Bélanger M.C., Beauchamp G., Ponzio N.M., Moïse N.S.: Atrial fibrillation in dogs with and without structural or functional cardiac disease: a retrospective study of 109 cases. J Vet Cardiol 2005, 7, 75–83. Menaut P. Bélanger M.C. Beauchamp G. Ponzio N.M. Moïse N.S. Atrial fibrillation in dogs with and without structural or functional cardiac disease: a retrospective study of 109 cases J Vet Cardiol 2005 7 75 8310.1016/j.jvc.2005.07.00219083323Search in Google Scholar

20Noszczyk-Nowak A., Michałek M., Kałuża E., Cepiel A., Pasławska U.: Prevalence of arrhythmias in dogs examined between 2008 and 2014. J Vet Res 2017, 61, 103–110. Noszczyk-Nowak A. Michałek M. Kałuża E. Cepiel A. Pasławska U. Prevalence of arrhythmias in dogs examined between 2008 and 2014 J Vet Res 2017 61 103 11010.1515/jvetres-2017-0013589440929978061Search in Google Scholar

21Prasad K., Gupta J.B., Kalra J., Lee P., Mantha S.V., Bharadwaj B.: Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 1996, 28, 375–385. Prasad K. Gupta J.B. Kalra J. Lee P. Mantha S.V. Bharadwaj B. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model J Mol Cell Cardiol 1996 28 375 38510.1006/jmcc.1996.00358729069Search in Google Scholar

22Rapti K., Diokmetzidou A., Kloukina I., Milner D.J., Varela A., Davos C.H., Capetanaki Y.: Opposite effects of catalase and MnSOD ectopic expression on stress induced defects and mortality in the desmin deficient cardiomyopathy model. Free Radic Biol Med 2017, 110, 206–218. Rapti K. Diokmetzidou A. Kloukina I. Milner D.J. Varela A. Davos C.H. Capetanaki Y. Opposite effects of catalase and MnSOD ectopic expression on stress induced defects and mortality in the desmin deficient cardiomyopathy model Free Radic Biol Med 2017 110 206 21810.1016/j.freeradbiomed.2017.06.01028629836Search in Google Scholar

23Rubio C.P., Hernández-Ruiz J., Martinez-Subiela S., Tvarijonaviciute A., Ceron J.J.: Spectrophotometric assays for total antioxidant capacity (TAC) in dog serum: an update. BMC Vet Res 2016, 12, 166. Rubio C.P. Hernández-Ruiz J. Martinez-Subiela S. Tvarijonaviciute A. Ceron J.J. Spectrophotometric assays for total antioxidant capacity (TAC) in dog serum: an update BMC Vet Res 2016 12 16610.1186/s12917-016-0792-7498636927526688Search in Google Scholar

24Sawyer D.B.: Oxidative stress in heart failure: what are we missing? Am J Med Sci 2011, 342, 120–124. Sawyer D.B. Oxidative stress in heart failure: what are we missing? Am J Med Sci 2011 342 120 12410.1097/MAJ.0b013e3182249fcd314581221747279Search in Google Scholar

25Svete A.N., Verk B., Seliškar A., Tomsič K., Križman P.J., Petrič A.D.: Plasma coenzyme Q10 concentration, antioxidant status, and serum N-terminal pro-brain natriuretic peptide concentration in dogs with various cardiovascular diseases and the effect of cardiac treatment on measured variables. Am J Vet Res 2017, 78, 447–457. Svete A.N. Verk B. Seliškar A. Tomsič K. Križman P.J. Petrič A.D. Plasma coenzyme Q10 concentration, antioxidant status, and serum N-terminal pro-brain natriuretic peptide concentration in dogs with various cardiovascular diseases and the effect of cardiac treatment on measured variables Am J Vet Res 2017 78 447 45710.2460/ajvr.78.4.44728346005Search in Google Scholar

26Tsutsui H., Kinugawa S., Matsushima S.: Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 2011, 301, 2181–2190. Tsutsui H. Kinugawa S. Matsushima S. Oxidative stress and heart failure Am J Physiol Heart Circ Physiol 2011 301 2181 219010.1152/ajpheart.00554.201121949114Search in Google Scholar

27Verk B., Nemec Svete A., Salobir J., Rezar V., Domanjko-Petrič A.: Markers of oxidative stress in dogs with heart failure. J Vet Diagn Invest 2017, 29, 636–644. Verk B. Nemec Svete A. Salobir J. Rezar V. Domanjko-Petrič A. Markers of oxidative stress in dogs with heart failure J Vet Diagn Invest 2017 29 636 64410.1177/104063871771199528580831Search in Google Scholar

28Wang J., He D., Zhang Q., Han Y., Jin S., Qi F.: Resveratrol protects against Cisplatin-induced cardiotoxicity by alleviating oxidative damage. Cancer Biother Radiopharm 2009, 24, 675–680. Wang J. He D. Zhang Q. Han Y. Jin S. Qi F. Resveratrol protects against Cisplatin-induced cardiotoxicity by alleviating oxidative damage Cancer Biother Radiopharm 2009 24 675 68010.1089/cbr.2009.067920025547Search in Google Scholar

29Yoo S., Aistrup G., Shiferaw Y., Ng J., Mohler P.J., Hund T.J., Waugh T., Browne S., Gussak G., Gilani M., Knight B.P., Passman R., Goldberger J.J., Wasserstrom J.A., Arora R.: Oxidative stress creates a unique, CaMKII-mediated substrate for atrial fibrillation in heart failure. JCI Insight 2018, 2, e120728. Yoo S. Aistrup G. Shiferaw Y. Ng J. Mohler P.J. Hund T.J. Waugh T. Browne S. Gussak G. Gilani M. Knight B.P. Passman R. Goldberger J.J. Wasserstrom J.A. Arora R. Oxidative stress creates a unique, CaMKII-mediated substrate for atrial fibrillation in heart failure JCI Insight 2018 2 e12072810.1172/jci.insight.120728623875430385719Search in Google Scholar